Analysen zu AB InBev SA-NV (Anheuser-Busch InBev)
14.03.24 | AB InBev Outperform | RBC Capital Markets | |
08.03.24 | AB InBev Overweight | JP Morgan Chase & Co. | |
05.03.24 | AB InBev Kaufen | DZ BANK | |
04.03.24 | AB InBev Outperform | RBC Capital Markets | |
04.03.24 | AB InBev Hold | Deutsche Bank AG | |
01.03.24 | AB InBev Overweight | Barclays Capital | |
01.03.24 | AB InBev Outperform | Bernstein Research | |
01.03.24 | AB InBev Hold | Deutsche Bank AG | |
01.03.24 | AB InBev Neutral | UBS AG | |
01.03.24 | AB InBev Overweight | JP Morgan Chase & Co. | |
29.02.24 | AB InBev Overweight | Barclays Capital | |
29.02.24 | AB InBev Outperform | RBC Capital Markets | |
29.02.24 | AB InBev Buy | Jefferies & Company Inc. | |
29.02.24 | AB InBev Outperform | Bernstein Research | |
28.02.24 | AB InBev Outperform | Bernstein Research | |
27.02.24 | AB InBev Hold | Deutsche Bank AG | |
26.02.24 | AB InBev Overweight | Barclays Capital | |
19.02.24 | AB InBev Buy | Jefferies & Company Inc. | |
06.02.24 | AB InBev Neutral | Goldman Sachs Group Inc. | |
25.01.24 | AB InBev Hold | Deutsche Bank AG | |
15.01.24 | AB InBev Overweight | Barclays Capital | |
12.01.24 | AB InBev Hold | Deutsche Bank AG | |
12.01.24 | AB InBev Neutral | UBS AG | |
12.01.24 | AB InBev Buy | Jefferies & Company Inc. | |
11.01.24 | AB InBev Overweight | JP Morgan Chase & Co. | |
10.01.24 | AB InBev Outperform | RBC Capital Markets | |
10.01.24 | AB InBev Overweight | JP Morgan Chase & Co. | |
10.01.24 | AB InBev Buy | Jefferies & Company Inc. | |
08.01.24 | AB InBev Outperform | Bernstein Research | |
08.01.24 | AB InBev Outperform | RBC Capital Markets | |
29.12.23 | AB InBev Hold | Jefferies & Company Inc. | |
12.12.23 | AB InBev Outperform | RBC Capital Markets | |
07.12.23 | AB InBev Hold | Deutsche Bank AG | |
05.12.23 | AB InBev Neutral | UBS AG | |
04.12.23 | AB InBev Hold | Deutsche Bank AG | |
29.11.23 | AB InBev Overweight | JP Morgan Chase & Co. | |
07.11.23 | AB InBev Buy | Deutsche Bank AG | |
06.11.23 | AB InBev Sell | UBS AG | |
03.11.23 | AB InBev Neutral | Goldman Sachs Group Inc. | |
02.11.23 | AB InBev Overweight | JP Morgan Chase & Co. | |
01.11.23 | AB InBev Buy | Deutsche Bank AG | |
01.11.23 | AB InBev Overweight | JP Morgan Chase & Co. | |
31.10.23 | AB InBev Hold | Jefferies & Company Inc. | |
31.10.23 | AB InBev Neutral | Goldman Sachs Group Inc. | |
31.10.23 | AB InBev Overweight | JP Morgan Chase & Co. | |
31.10.23 | AB InBev Outperform | Bernstein Research | |
31.10.23 | AB InBev Hold | Jefferies & Company Inc. | |
31.10.23 | AB InBev Sell | UBS AG | |
11.10.23 | AB InBev Outperform | Bernstein Research | |
09.10.23 | AB InBev Sell | UBS AG |
Aktuelle Aktienanalysen
15.09.25 | easyJet Market-Perform | Bernstein Research | |
15.09.25 | Continental Buy | UBS AG | |
15.09.25 | Delivery Hero Buy | UBS AG | |
15.09.25 | Evonik Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.09.25 | Michelin Buy | UBS AG | |
15.09.25 | Akzo Nobel Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.09.25 | Bayer Neutral | UBS AG | |
15.09.25 | Akzo Nobel Neutral | UBS AG | |
15.09.25 | Brenntag Neutral | UBS AG | |
15.09.25 | Air Liquide Buy | UBS AG | |
15.09.25 | Symrise Buy | UBS AG | |
15.09.25 | WACKER CHEMIE Buy | UBS AG | |
15.09.25 | LANXESS Neutral | UBS AG | |
15.09.25 | Evonik Neutral | UBS AG | |
15.09.25 | Covestro Neutral | UBS AG | |
15.09.25 | BASF Neutral | UBS AG | |
15.09.25 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
15.09.25 | Rheinmetall Hold | Warburg Research | |
15.09.25 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.09.25 | IONOS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.09.25 | HUGO BOSS Outperform | RBC Capital Markets | |
15.09.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
15.09.25 | Rheinmetall Buy | Jefferies & Company Inc. | |
15.09.25 | UBS Buy | Jefferies & Company Inc. | |
15.09.25 | Oracle Buy | Jefferies & Company Inc. | |
15.09.25 | Apple Hold | Jefferies & Company Inc. | |
15.09.25 | Apple Overweight | JP Morgan Chase & Co. | |
15.09.25 | Fresenius Medical Care Underperform | Jefferies & Company Inc. | |
15.09.25 | Airbus Outperform | RBC Capital Markets | |
15.09.25 | WACKER CHEMIE Neutral | JP Morgan Chase & Co. | |
15.09.25 | Fresenius Buy | Jefferies & Company Inc. | |
12.09.25 | Givaudan Hold | Jefferies & Company Inc. | |
12.09.25 | Symrise Underperform | Jefferies & Company Inc. | |
12.09.25 | Wolters Kluwer Outperform | Bernstein Research | |
12.09.25 | Prosus Buy | UBS AG | |
12.09.25 | Novartis Neutral | UBS AG | |
12.09.25 | BBVA Outperform | RBC Capital Markets | |
12.09.25 | RWE Buy | UBS AG | |
12.09.25 | Wolters Kluwer Neutral | UBS AG | |
12.09.25 | Swiss Re Buy | UBS AG | |
12.09.25 | Merck Market-Perform | Bernstein Research | |
12.09.25 | Münchener Rückversicherungs-Gesellschaft Neutral | UBS AG | |
12.09.25 | Deutsche Telekom Outperform | Bernstein Research | |
12.09.25 | Sanofi Buy | Deutsche Bank AG | |
12.09.25 | Münchener Rückversicherungs-Gesellschaft Hold | Jefferies & Company Inc. | |
12.09.25 | Hannover Rück Buy | Jefferies & Company Inc. | |
12.09.25 | Swiss Re Hold | Jefferies & Company Inc. | |
12.09.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
12.09.25 | Assicurazioni Generali Buy | Jefferies & Company Inc. | |
12.09.25 | AXA Buy | Jefferies & Company Inc. |